VP6-2022: Adjuvant pertuzumab and trastuzumab in patients with early HER-2 positive breast cancer in APHINITY: 8.4 years' follow-up

Sibylle Loibl, Jacek Jassem, Amir Sonnenblick, Damien Parlier, Eric P. Winer, Jonas Bergh, R.D. Gelber, Eleonora Restuccia, Y-H Im, Chao‐Yuan Huang,

Annals of Oncology · 2022 · 52 citations · 0 references

DOIFull text

Open access

Concepts